- 专利标题： Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
-
申请号： US13744131申请日： 2013-01-17
-
公开(公告)号： US20130336960A1公开(公告)日： 2013-12-19
- 发明人: Herbert Andres , Sanne Lysbet De Haas , Rebecca Elliott , Johann Karl , Yu-Ju Gloria Meng , Gregory D. Plowman , Stefan Scherer , Norbert Wild
- 申请人： Hoffmann-La Roche Inc. , Genentech. Inc.
- 申请人地址： US CA South San Francisco US NJ Nutley
- 专利权人： GENENTECH. INC.,HOFFMANN-LA ROCHE INC.
- 当前专利权人： GENENTECH. INC.,HOFFMANN-LA ROCHE INC.
- 当前专利权人地址： US CA South San Francisco US NJ Nutley
- 优先权： EP10170004.5 20100719; EP10170008.6 20100719
- 主分类号： G01N33/68
- IPC分类号： G01N33/68 ; A61K45/06 ; A61K39/395
摘要：
The invention provides methods for identifying patient who may benefit from treatment with an anti-cancer therapy comprising a VEGF antagonist. The invention also provides methods for monitoring a patients' response to the anti-cancer therapy. The invention also provides kits and articles of manufacture for use in the methods.
信息查询
IPC分类:
